Abstract
OBJECTIVE
The diagnosis of hypothalamic-pituitary-adrenal insufficiency (HPAI) is a major clinical challenge. The gold standard procedure remains insulin tolerance test (ITT). This study aimed to evaluate the usefulness of standard-dose corticotrophin stimulation test (SDCT) in diagnosing HPAI.
DESIGN
In this prospective study we performed SDCT and ITT in 55 consecutive patients (37F/18M) affected by pituitary disorders.
RESULTS
A normal response to ITT was found in 44 patients, while HPAI was diagnosed in 11. Using ITT as reference test, the ROC curve showed that a cortisol value of 18 µg/dl (500 nmol/L) at 30 min or 21.8 µg/dl (600 nmol/L) at 60 min after SDCT represents the best compromise between sensitivity and specificity in diagnosing HPAI. Moreover, 30 min cortisol values >20.3 µg/dl (560 nmol/L) or 60 min cortisol values >24.1 µg/dl (665 nmol/L) exclude HPAI. Four out of 15 patients of Group A, previously non-respondent to SDCT, showed a normal response to a second SDCT.
CONCLUSIONS
SDCT is not a reliable tool to identify HPAI, but it appears to be more useful in confirming the normality of HPA function. When SDCT fails to exclude HPAI, ITT should be performed. If ITT is contraindicated, retesting patients by SDCT is useful before starting an unnecessary replacement therapy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Kazlauskaite R, Evans AT, Villabona CV, et al, 2008 Consortium for Evaluation of Corticotropin test in Hypothalamic-Pituitary Adrenal Insufficiency. Corticotropin tests for hypothalamic-pituitary-adrenal insufficiency: a metaanalysis. J Clin Endocrinol Metab 93: 4245–4253.
Abdu TA, Elhadd TA, Neary R, Clayton RN, 1999 Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab 84: 838–843.
Tordjman K, Jaffe A, Trostanetsky Y, Greenman Y, Limor R, Stern N, 2000 Low-dose (1 microgram) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 microgram) test. Clin Endocrinol (Oxf) 52: 633–640.
Giordano R, Picu A, Bonelli L, et al, 2008 Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative tests. Clin Endocrinol (Oxf) 68: 935–941.
Finucane FM, Liew A, Thornton E, Rogers B, Tormey W, Agha A, 2008 Clinical insights into the safety and utility of the insulin tolerance test (ITT) in the assessment of the hypothalamo-pituitary-adrenal axis. Clin Endocrinol (Oxf) 69: 603–607.
Berg C, Meinel T, Lahner H, Yuece A, Mann K, Petersenn S, 2010 Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery. Eur J Endocrinol 162: 477–482.
Dökmetaş HS, Colak R, Keleştimur F, Selçuklu A, Unlühizarci K, Bayram F, 2000 A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery. J Clin Endocrinol Metab 85: 3713–3719.
Courtney CH, McAllister AS, McCance DR, et al, 2000 Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis. Clin Endocrinol (Oxf) 53: 431–436.
Courtney CH, McAllister AS, Bell PM, et al, 2004 Low- and standard-dose corticotropin and insulin hypoglycemia testing in the assessment of hypothalamic-pituitary-adrenal function after pituitary surgery. J Clin Endocrinol Metab 89: 1712–1717.
Klose M, Lange M, Kosteljanetz M, Poulsgaard L, Feldt-Rasmussen U, 2005 Adrenocortical insufficiency after pituitary surgery: an audit of the reliability of the conventional short synacthen test. Clin Endocrinol (Oxf) 63: 499–505.
Agha A, Tomlinson JW, Clark PM, Holder G, Stewart PM, 2006 The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 91: 43–47.
Siyambalapitiya S, Ibbotson V, Doane A, Ghigo E, Campbell MJ, Ross RJ, 2007 Combining growth hormone releasing hormone-arginine and synacthen testing diminishes the cortisol response. J Clin Endocrinol Metab 92: 853–856.
Ambrosi B, Barbetta L, Re T, Passini E, Faglia G, 1998 The one microgram adrenocorticotropin test in the assessment of hypothalamic-pituitary-adrenal function. Eur J Endocrinol 139: 575–579.
Giavoli C, Libé R, Corbetta S, et al, 2004 Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients. J Clin Endocrinol Metab 89: 5397–5401.
Dorin RI, Qualls CR, Crapo LM, 2003 Diagnosis of adrenal insufficiency. Ann Intern Med 139: 194–204.
Stewart PM, Corrie J, Seckl JR, Edwards CR, Padfield PL, 1988 A rational approach for assessing the hypothalamo-pituitary-adrenal axis. Lancet 8596: 1208–1210.
Arlt W, 2009 The approach to the adult with newly diagnosed adrenal insufficiency. J Clin Endocrinol Metab 94: 1059–1067.
Pfeifer M, Kanc K, Verhovec R, Kocijancic A, 2001 Reproducibility of the insulin tolerance test (ITT) for assessment of growth hormone and cortisol secretion in normal and hypopituitary adult men. Clin Endocrinol (Oxf) 54: 17–22.
Tsatsoulis A, Shalet SM, Harrison J, Ratcliffe WA, Beardwell CG, Robinson EL, 1988 Adrenocorticotrophin (ACTH) deficiency undetected by standard dynamic tests of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) 28: 225–232.
Gonzálbez J, Villabona C, Ramón J, et al, 2000 Establishment of reference values for standard dose short synacthen test (250 microgram), low dose short synacthen test (1 microgram) and insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in normal subjects. Clin Endocrinol (Oxf) 53: 199–204.
Gleeson HK, Walker BR, Seckl JR, Padfield PL, 2003 Ten years on: Safety of short synacthen tests in assessing adrenocorticotropin deficiency in clinical practice. J Clin Endocrinol Metab 88: 2106–2111.
Clark PM, Neylon I, Raggatt PR, Sheppard MC, Stewart PM, 1998 Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol (Oxf) 49: 287–292.
Plumpton FS, Besser GM, 1968 The adrenocortical response to surgery and insulin-induced hypoglycemia in corticosteroid-treated and normal subjects. Br J Surg 55: 857.
Author information
Authors and Affiliations
Corresponding author
Additional information
The two authors contributed equally to the study
Rights and permissions
About this article
Cite this article
Ferrante, E., Morelli, V., Giavoli, C. et al. Is the 250 µg ACTH test a useful tool for the diagnosis of central hypoadrenalism in adult patients with pituitary disorders?. Hormones 11, 428–435 (2012). https://doi.org/10.14310/horm.2002.1374
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14310/horm.2002.1374